腸内健康栄養補助食品市場：製品、形態、流通シャネル別-2025-2030年の世界予測

腸内健康栄養補助食品市場は、2023年に112億9,000万米ドルと評価され、2024年には120億7,000万米ドルに達すると予測され、CAGR 7.43％で成長し、2030年には186億5,000万米ドルに達すると予測されています。

腸内健康栄養補助食品市場には、プロバイオティクス、プレバイオティクス、繊維、植物エキスなどの成分を活用し、消化器系の健康をサポートするように設計された栄養補助食品や機能性食品が含まれます。これらの製品は、全体的な幸福感、免疫力、精神的健康において腸の健康が果たす重要な役割に対する消費者の意識の高まりに応えるものとして不可欠です。用途は様々な年齢層に及び、最終用途は一般家庭、ヘルスケア施設、健康志向の個人など多岐にわたる。市場の成長は、予防医療に対する消費者の志向の高まりと、革新的な製品処方が、腸脳軸の重要性の科学的検証と相まって、成長を促進しています。消化器系疾患の罹患率が上昇していることも、個別化栄養の動向と同様に需要を促進しています。主なビジネスチャンスは、eコマース・プラットフォームを含む流通チャネルの拡大と、地域の食習慣に対応した地域特化型製品の開発にあります。企業は、菜食主義者やアレルゲンフリー製剤などのニッチをターゲットに、新規成分や送達技術を発見するための研究開発に投資することで、こうした機会を活用することができます。消費者教育のためのヘルスケア・プロバイダーとのコラボレーションは、市場浸透をさらに高めることができます。

楽観的な見方にもかかわらず、市場は、有効性と安全性に関する主張に関する規制当局の監視など、製品承認に厳格な臨床エビデンスを必要とする課題に直面しています。高品質の原材料や製造工程にかかるコストが高いことも、市場の成長を妨げる可能性があります。さらに、地域によって異なる規制や、誤った情報による消費者の懐疑心が、可能性を制限することもあります。サプライチェーンの合理化、成分の生物学的利用能の向上、プロバイオティクスとプレバイオティクスを組み合わせたシンバイオティクスの開発など、イノベーションと研究の機会は豊富にあります。ビッグデータと人工知能を統合して消費者行動を分析し、動向を予測することで、実用的な洞察が得られます。市場は急速なイノベーションを特徴とするダイナミックな市場であるが、細分化されているため、M&Aによる地位固めの可能性が示唆されます。持続可能性、透明性、規制遵守に戦略的に焦点を当てることが、市場シェア拡大における差別化要因として浮上する可能性があります。

市場力学：急速に進化する腸内健康栄養補助食品市場における主要市場インサイトの解明

腸内健康栄養補助食品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 腸の健康の利点に関する消費者の知識の増加
  • 世界の胃腸障害の有病率の上昇
  • 予防ヘルスケアとウェルネス動向へのシフト
• 市場抑制要因
  • 腸内健康栄養補助食品の承認に関する政府の厳しい規制
• 市場機会
  • オーダーメイドの腸内健康ソリューションのための個別化栄養の可能性
  • 腸内健康栄養補助食品のeコマースプラットフォームへの展開
• 市場の課題
  • 栄養補助食品の有効性に対する懐疑論

ポーターのファイブフォース：腸内健康栄養補助食品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：腸内健康栄養補助食品市場における外部からの影響の把握

外部マクロ環境要因は、腸内健康栄養補助食品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析腸内健康栄養補助食品市場における競合情勢の把握

腸内健康栄養補助食品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス腸内健康栄養補助食品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、腸内健康栄養補助食品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨腸内健康栄養補助食品市場における成功への道筋を描く

腸内健康栄養補助食品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腸の健康の利点に関する消費者の知識の向上
    • 世界中で胃腸疾患の罹患率が上昇
    • 予防ヘルスケアと健康志向の動向への移行
  • 抑制要因
    • 腸内健康栄養補助食品の承認に関する厳格な政府規制
  • 機会
    • 腸の健康のためのカスタマイズされた栄養ソリューションの可能性
    • 腸内健康栄養補助食品のeコマースプラットフォームへの展開
  • 課題
    • 栄養補助食品の有効性に対する懐疑論
• 市場セグメンテーション分析
  • 製品：腸内細菌叢のバランスを整える効果によりプロバイオティクスの人気が高まっている
  • フォーム：保管や輸送の利便性と耐久性により、腸内健康栄養補助食品のタブレットフォームの採用が拡大しています。
  • 配信チャネル：腸内健康栄養補助食品のオンライン配信チャネルの進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 腸内健康栄養補助食品市場：製品別

• 酵素
• フルボ酸
• プレバイオティクス
• プロバイオティクス

第7章 腸内健康栄養補助食品市場：形態別

• カプセル
• 液体
• 粉末
• タブレット

第8章 腸内健康栄養補助食品市場流通チャネル別

• オフライン
• オンライン

第9章 南北アメリカの腸内健康栄養補助食品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の腸内健康栄養補助食品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの腸内健康栄養補助食品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Acutiaが消化器系の健康のための総合的な栄養補助食品を堆肥化可能なパッケージで発売
  • ネスレヘルスサイエンス、腸の健康改善のための「リソースファイバーチョイス」を発売
  • Nutrazeeが消化と免疫の健康のためのプロバイオティクスグミを発表
• 戦略分析と提言

企業一覧

• Alimentary Health Limited
• Amway Corporation
• Archer-Daniels-Midland Company
• BASF SE
• Bayer AG
• FANCL Corporation
• Garden of Life
• Glanbia Nutritional
• GNC Holdings Inc.
• HealthForce'
• Herbalife Nutrition Ltd.
• Himalaya Wellness Company
• Koninklijke DSM N.V.
• Lonza Group Ltd
• Nestle Health Science S.A.
• NOW Health Group, Inc.
• Nutrica NV by Danone S.A.
• Olly Nutrition
• PanTheryx Inc.
• Pfizer Inc.
• Sanofi S.A.
• The Nature's Bounty Co.
• Zenwise, LLC

LIST OF FIGURES

• FIGURE 1. GUT HEALTH NUTRACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GUT HEALTH NUTRACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GUT HEALTH NUTRACEUTICALS MARKET DYNAMICS
• TABLE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 30. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 47. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 50. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 102. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 114. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 116. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 117. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
• TABLE 147. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

The Gut Health Nutraceuticals Market was valued at USD 11.29 billion in 2023, expected to reach USD 12.07 billion in 2024, and is projected to grow at a CAGR of 7.43%, to USD 18.65 billion by 2030.

The Gut Health Nutraceuticals market encompasses dietary supplements and functional foods designed to support digestive health, leveraging ingredients like probiotics, prebiotics, fibers, and plant extracts. These products are essential as they cater to a growing consumer awareness about the crucial role of gut health in overall well-being, immunity, and mental health. Applications extend across various age groups, with end-use spanning households, healthcare facilities, and health-conscious individuals. Market growth is propelled by increasing consumer inclination towards preventive healthcare, and innovative product formulations, coupled with scientific validation of gut-brain axis significance, foster growth. The rising incidence of digestive disorders fuels demand, as does the trend of personalized nutrition. Key opportunities lie in expanding distribution channels, including e-commerce platforms, and developing region-specific products addressing local dietary habits. Companies can capitalize on these opportunities by investing in R&D to discover novel ingredients and delivery technologies, targeting niches such as vegan or allergen-free formulations. Collaborations with healthcare providers for consumer education can further enhance market penetration.

Despite optimism, the market faces challenges, such as regulatory scrutiny concerning claims around efficacy and safety, necessitating rigorous clinical evidence for product approval. The high cost of quality raw materials and production processes can impede market growth. Additionally, varying regional regulations and consumer skepticism due to misinformation can limit potential. Innovation and research opportunities are abundant in streamlining supply chains, enhancing bioavailability of ingredients, and developing synbiotics - a combination of pro- and prebiotics. Integrating big data and artificial intelligence to analyze consumer behavior and predict trends can provide actionable insights. The market is dynamic, characterized by rapid innovations, yet fragmented, suggesting potential for mergers and acquisitions to consolidate positions. A strategic focus on sustainability, transparency, and regulatory compliance can emerge as differentiators in capturing greater market share.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gut Health Nutraceuticals Market

The Gut Health Nutraceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing consumer knowledge about the benefits of gut health
  • Rising prevalence of gastrointestinal disorders worldwide
  • Shift towards preventive healthcare and wellness trends
• Market Restraints
  • Strict government regulations for approvals of gut health nutraceuticals
• Market Opportunities
  • Potential for personalized nutrition for tailored gut health solutions
  • Deployment of gut health nutraceuticals on eCommerce platforms
• Market Challenges
  • Skepticism about the efficacy of nutraceutical products

Porter's Five Forces: A Strategic Tool for Navigating the Gut Health Nutraceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gut Health Nutraceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gut Health Nutraceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gut Health Nutraceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gut Health Nutraceuticals Market

A detailed market share analysis in the Gut Health Nutraceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gut Health Nutraceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gut Health Nutraceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gut Health Nutraceuticals Market

A strategic analysis of the Gut Health Nutraceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gut Health Nutraceuticals Market, highlighting leading vendors and their innovative profiles. These include Alimentary Health Limited, Amway Corporation, Archer-Daniels-Midland Company, BASF SE, Bayer AG, FANCL Corporation, Garden of Life, Glanbia Nutritional, GNC Holdings Inc., HealthForce', Herbalife Nutrition Ltd., Himalaya Wellness Company, Koninklijke DSM N.V., Lonza Group Ltd, Nestle Health Science S.A., NOW Health Group, Inc., Nutrica NV by Danone S.A., Olly Nutrition, PanTheryx Inc., Pfizer Inc., Sanofi S.A., The Nature's Bounty Co., and Zenwise, LLC.

Market Segmentation & Coverage

This research report categorizes the Gut Health Nutraceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Enzymes, Fulvic Acid, Prebiotics, and Probiotics.
• Based on Form, market is studied across Capsules, Liquids, Powders, and Tablets.
• Based on Distribution Chanel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumer knowledge about the benefits of gut health
    • 5.1.1.2. Rising prevalence of gastrointestinal disorders worldwide
    • 5.1.1.3. Shift towards preventive healthcare and wellness trends
  • 5.1.2. Restraints
    • 5.1.2.1. Strict government regulations for approvals of gut health nutraceuticals
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential for personalized nutrition for tailored gut health solutions
    • 5.1.3.2. Deployment of gut health nutraceuticals on eCommerce platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Skepticism about the efficacy of nutraceutical products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for probiotics owing to its contribution in balancing gut microbiota
  • 5.2.2. Form: Growing adoption of a tablet form of gut health nutraceuticals due to convenience and durability for storage and transport.
  • 5.2.3. Distribution Chanel: Evolving online distribution channels for gut health nutraceuticals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gut Health Nutraceuticals Market, by Product

• 6.1. Introduction
• 6.2. Enzymes
• 6.3. Fulvic Acid
• 6.4. Prebiotics
• 6.5. Probiotics

7. Gut Health Nutraceuticals Market, by Form

• 7.1. Introduction
• 7.2. Capsules
• 7.3. Liquids
• 7.4. Powders
• 7.5. Tablets

8. Gut Health Nutraceuticals Market, by Distribution Chanel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Americas Gut Health Nutraceuticals Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Gut Health Nutraceuticals Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Gut Health Nutraceuticals Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Acutia Launches Holistic Dietary Supplement for Digestive Health In Compostable Packaging
  • 12.3.2. Nestle Health Science launches 'Resource Fiber Choice' to improve gut health
  • 12.3.3. Nutrazee Unveils Probiotic Gummies For Digestive And Immune Health
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alimentary Health Limited
• 2. Amway Corporation
• 3. Archer-Daniels-Midland Company
• 4. BASF SE
• 5. Bayer AG
• 6. FANCL Corporation
• 7. Garden of Life
• 8. Glanbia Nutritional
• 9. GNC Holdings Inc.
• 10. HealthForce'
• 11. Herbalife Nutrition Ltd.
• 12. Himalaya Wellness Company
• 13. Koninklijke DSM N.V.
• 14. Lonza Group Ltd
• 15. Nestle Health Science S.A.
• 16. NOW Health Group, Inc.
• 17. Nutrica NV by Danone S.A.
• 18. Olly Nutrition
• 19. PanTheryx Inc.
• 20. Pfizer Inc.
• 21. Sanofi S.A.
• 22. The Nature's Bounty Co.
• 23. Zenwise, LLC